Company / EPS (Diluted)
Encompass Health EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$3.47
FY2025
5-year range
$2.70 / $4.11
FY2021-FY2025
Trend
+28.5%
vs FY2024
Sector context
#44 of 159
Health Care
What the data says
At $3.47, Encompass Health's eps (diluted) ranks #44 of 159 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $2.59 in FY2018 to $4.11 in FY2023.
Based on SEC 10-K filings.
3.47 in FY2025 with a 5-year CAGR of +3.4%.
Declined from $4.11 to $3.47 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +6.8%
- 5-Year CAGR
- +3.4%
- 10-Year CAGR
- -
Sector benchmark
#44 of 159 in Health CareTop 28% of 159This company $3.47 Sector average $1.67
▼
+108.0% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 28.5% year-over-year.
- Ranks #44 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.47 | +28.5% |
| FY2024 | $2.70 | -34.3% |
| FY2023 | $4.11 | +44.2% |
| FY2022 | $2.85 | -21.1% |
| FY2021 | $3.61 | +23.2% |
| FY2020 | $2.93 | +3.2% |
| FY2019 | $2.84 | +9.7% |
| FY2018 | $2.59 | -8.8% |
| FY2017 | $2.84 | +9.7% |
| FY2016 | $2.59 | +35.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026